Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Carter Gould is an analyst at Barclays. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/10/2024 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 2.12% | $43 → $41 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | LLY | Buy Now | Eli Lilly and Co | $953.00 | 7.56% | $913 → $1025 | Maintains | Overweight | Get Alert |
| 07/10/2024 | PFE | Buy Now | Pfizer | $29.20 | 2.74% | $28 → $30 | Maintains | Equal-Weight | Get Alert |
| 07/10/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | 10.89% | $1050 → $1200 | Maintains | Overweight | Get Alert |
| 06/13/2024 | BRNS | Buy Now | Barinthus Biotherapeutics | $1.43 | 109.79% | $7 → $3 | Maintains | Overweight | Get Alert |
| 06/11/2024 | GERN | Buy Now | Geron | $4.92 | 82.93% | → $9 | Initiates | → Overweight | Get Alert |
| 05/23/2024 | CYTK | Buy Now | Cytokinetics | $57.39 | 65.53% | $100 → $95 | Maintains | Overweight | Get Alert |
| 05/03/2024 | AMGN | Buy Now | Amgen | $330.34 | -9.18% | $230 → $300 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 05/02/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | 14.19% | $150 → $169 | Maintains | Overweight | Get Alert |
| 04/29/2024 | GILD | Buy Now | Gilead Sciences | $70.81 | 7.32% | $80 → $76 | Maintains | Equal-Weight | Get Alert |
| 04/29/2024 | ABBV | Buy Now | AbbVie | $168.03 | 11.29% | $195 → $187 | Maintains | Overweight | Get Alert |
| 04/26/2024 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 7.1% | $51 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/25/2024 | BIIB | Buy Now | Biogen | $222.07 | -9.94% | $215 → $200 | Maintains | Equal-Weight | Get Alert |
| 04/16/2024 | SKIL | Buy Now | Skillsoft | $15.87 | 26.02% | $25 → $20 | Maintains | Overweight | Get Alert |
| 04/04/2024 | BIIB | Buy Now | Biogen | $222.07 | -3.18% | $230 → $215 | Maintains | Equal-Weight | Get Alert |
| 03/27/2024 | ABBV | Buy Now | AbbVie | $168.03 | 16.05% | $185 → $195 | Maintains | Overweight | Get Alert |
| 02/29/2024 | ACLX | Buy Now | Arcellx | $63.35 | 15.23% | $62 → $73 | Maintains | Overweight | Get Alert |
| 02/12/2024 | GILD | Buy Now | Gilead Sciences | $70.81 | 12.97% | $85 → $80 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | LLY | Buy Now | Eli Lilly | $953.00 | -15.01% | $680 → $810 | Maintains | Overweight | Get Alert |
| 02/05/2024 | ABBV | Buy Now | AbbVie | $168.03 | 10.1% | $175 → $185 | Maintains | Overweight | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $128.30 | 13.02% | $135 → $145 | Maintains | Overweight | Get Alert |
| 01/23/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -5.74% | $935 → $1020 | Maintains | Overweight | Get Alert |
| 01/23/2024 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | 1.35% | $145 → $150 | Maintains | Overweight | Get Alert |
| 01/23/2024 | MRK | Buy Now | Merck & Co | $128.30 | 5.22% | $130 → $135 | Maintains | Overweight | Get Alert |
| 01/23/2024 | GILD | Buy Now | Gilead Sciences | $70.81 | 20.03% | $82 → $85 | Maintains | Equal-Weight | Get Alert |
| 01/23/2024 | LLY | Buy Now | Eli Lilly | $953.00 | -28.65% | $630 → $680 | Maintains | Overweight | Get Alert |
| 01/23/2024 | ABBV | Buy Now | AbbVie | $168.03 | 4.15% | $170 → $175 | Maintains | Overweight | Get Alert |
| 01/17/2024 | ALLK | Buy Now | Allakos | $0.91 | 10.36% | $1.5 → $1 | Maintains | Underweight | Get Alert |
| 12/14/2023 | PFE | Buy Now | Pfizer | $29.20 | -4.11% | $34 → $28 | Maintains | Equal-Weight | Get Alert |
| 12/06/2023 | SKIL | Buy Now | Skillsoft | $15.87 | 89.04% | $37 → $30 | Maintains | Overweight | Get Alert |
| 11/16/2023 | ACLX | Buy Now | Arcellx | $63.35 | -2.13% | $49 → $62 | Maintains | Overweight | Get Alert |
| 11/14/2023 | ALLK | Buy Now | Allakos | $0.91 | 65.54% | $2.5 → $1.5 | Maintains | Underweight | Get Alert |
| 11/01/2023 | PFE | Buy Now | Pfizer | $29.20 | 16.44% | $35 → $34 | Maintains | Equal-Weight | Get Alert |
| 10/30/2023 | ABBV | Buy Now | AbbVie | $168.03 | 1.17% | $160 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 10/27/2023 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 27.02% | $60 → $51 | Maintains | Equal-Weight | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $9.78 | 22.7% | $31 → $12 | Maintains | Overweight | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -14.52% | $900 → $925 | Maintains | Overweight | Get Alert |
| 08/18/2023 | SKIL | Buy Now | Skillsoft | $15.87 | -84.25% | $58 → $50 | Maintains | Overweight | Get Alert |
| 08/09/2023 | LLY | Buy Now | Eli Lilly | $953.00 | -38.09% | $500 → $590 | Maintains | Overweight | Get Alert |
| 08/08/2023 | BIIB | Buy Now | Biogen | $222.07 | 32.39% | $311 → $294 | Maintains | Equal-Weight | Get Alert |
| 08/07/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -16.83% | $888 → $900 | Maintains | Overweight | Get Alert |
| 08/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $110 → $172 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 54.42% | $64 → $62 | Maintains | Equal-Weight | Get Alert |
| 07/24/2023 | GILD | Buy Now | Gilead Sciences | $70.81 | 12.97% | $81 → $80 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | PFE | Buy Now | Pfizer | $29.20 | 30.14% | $40 → $38 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | GILD | Buy Now | Gilead Sciences | $70.81 | 14.38% | $84 → $81 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 59.4% | $65 → $64 | Maintains | Equal-Weight | Get Alert |
| 07/11/2023 | AMGN | Buy Now | Amgen | $330.34 | -36.43% | $225 → $210 | Maintains | Underweight | Get Alert |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -17.94% | $915 → $888 | Maintains | Overweight | Get Alert |
| 06/28/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $98 → $110 | Maintains | Overweight | Get Alert |
| 06/08/2023 | BIIB | Buy Now | Biogen | $222.07 | — | — | Maintains | Overweight | Get Alert |
| 06/07/2023 | SKIL | Buy Now | Skillsoft | $15.87 | -81.73% | $70 → $58 | Maintains | Overweight | Get Alert |
| 05/11/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $90 → $98 | Maintains | Overweight | Get Alert |
| 05/09/2023 | ACLX | Buy Now | Arcellx | $63.35 | -22.65% | $38 → $49 | Maintains | Overweight | Get Alert |
| 05/05/2023 | ALEC | Buy Now | Alector | $5.73 | 109.42% | $14 → $12 | Maintains | Overweight | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -15.54% | $131 → $125 | Maintains | Overweight | Get Alert |
| 05/03/2023 | PFE | Buy Now | Pfizer | $29.20 | 36.99% | $43 → $40 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | MRK | Buy Now | Merck & Co | $128.30 | 1.33% | $128 → $130 | Maintains | Overweight | Get Alert |
| 05/01/2023 | LLY | Buy Now | Eli Lilly | $953.00 | -55.93% | $400 → $420 | Maintains | Overweight | Get Alert |
| 05/01/2023 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 61.89% | $66 → $65 | Maintains | Equal-Weight | Get Alert |
| 05/01/2023 | AMGN | Buy Now | Amgen | $330.34 | -31.89% | $227 → $225 | Maintains | Underweight | Get Alert |
| 04/26/2023 | BIIB | Buy Now | Biogen | $222.07 | 35.99% | $307 → $302 | Maintains | Equal-Weight | Get Alert |
| 04/14/2023 | AMGN | Buy Now | Amgen | $330.34 | -31.28% | $230 → $227 | Maintains | Underweight | Get Alert |
| 04/13/2023 | ABBV | Buy Now | AbbVie | $168.03 | -4.78% | $155 → $160 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | PFE | Buy Now | Pfizer | $29.20 | 47.26% | $44 → $43 | Maintains | Equal-Weight | Get Alert |
| 04/12/2023 | SKIL | Buy Now | Skillsoft | $15.87 | -77.95% | $80 → $70 | Maintains | Overweight | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -15.44% | $815 → $915 | Maintains | Overweight | Get Alert |
| 03/21/2023 | GOSS | Buy Now | Gossamer Bio | $1.18 | 27.12% | $2 → $1.5 | Maintains | Equal-Weight | Get Alert |
| 03/01/2023 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $50 → $90 | Maintains | Overweight | Get Alert |
| 02/21/2023 | TVTX | Buy Now | Travere Therapeutics | $9.78 | 216.97% | $37 → $31 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -11.49% | $136 → $131 | Maintains | Overweight | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $330.34 | -30.37% | $240 → $230 | Maintains | Underweight | Get Alert |
| 02/01/2023 | PFE | Buy Now | Pfizer | $29.20 | 50.68% | $49 → $44 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | GILD | Buy Now | Gilead Sciences | $70.81 | 18.62% | $76 → $84 | Maintains | Equal-Weight | Get Alert |
| 01/18/2023 | AMGN | Buy Now | Amgen | $330.34 | -27.35% | $234 → $240 | Maintains | Underweight | Get Alert |
| 01/03/2023 | LLY | Buy Now | Eli Lilly | $953.00 | -58.03% | $395 → $400 | Maintains | Overweight | Get Alert |
| 12/12/2022 | ACLX | Buy Now | Arcellx | $63.35 | -40.02% | $25 → $38 | Maintains | Overweight | Get Alert |
| 12/07/2022 | GOSS | Buy Now | Gossamer Bio | $1.18 | 69.49% | $18 → $2 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 11/30/2022 | BIIB | Buy Now | Biogen | $222.07 | 40.95% | $275 → $313 | Maintains | Equal-Weight | Get Alert |
| 11/11/2022 | VOR | Buy Now | Vor Biopharma | $0.97 | 1445.28% | $26 → $15 | Maintains | Overweight | Get Alert |
| 11/11/2022 | MTEM | Buy Now | Molecular Templates | $1.38 | -27.54% | $67.5 → $15 | Maintains | Overweight | Get Alert |
| 11/09/2022 | RETA | Buy Now | Reata Pharmaceuticals | — | — | $43 → $50 | Maintains | Overweight | Get Alert |
| 11/02/2022 | PFE | Buy Now | Pfizer | $29.20 | 67.81% | $44 → $49 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $953.00 | -58.55% | $355 → $395 | Maintains | Overweight | Get Alert |
| 10/31/2022 | ABBV | Buy Now | AbbVie | $168.03 | -7.75% | $160 → $155 | Maintains | Equal-Weight | Get Alert |
| 10/31/2022 | GILD | Buy Now | Gilead Sciences | $70.81 | 7.32% | $60 → $76 | Upgrade | Underweight → Equal-Weight | Get Alert |
| 10/31/2022 | AMGN | Buy Now | Amgen | $330.34 | -29.16% | → $234 | Downgrade | Equal-Weight → Underweight | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $128.30 | -14.26% | $105 → $110 | Maintains | Overweight | Get Alert |
| 10/12/2022 | PFE | Buy Now | Pfizer | $29.20 | 50.68% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | GILD | Buy Now | Gilead Sciences | $70.81 | -15.27% | $56 → $60 | Maintains | Underweight | Get Alert |
| 10/12/2022 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 64.38% | $69 → $66 | Maintains | Equal-Weight | Get Alert |
| 10/12/2022 | AMGN | Buy Now | Amgen | $330.34 | -29.16% | $236 → $234 | Maintains | Equal-Weight | Get Alert |
| 10/07/2022 | BIIB | Buy Now | Biogen | $222.07 | 23.83% | $200 → $275 | Maintains | Equal-Weight | Get Alert |
| 09/09/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -24.68% | $735 → $815 | Maintains | Overweight | Get Alert |
| 08/18/2022 | GOSS | Buy Now | Gossamer Bio | $1.18 | 1425.42% | $12 → $18 | Maintains | Overweight | Get Alert |
| 08/16/2022 | APLT | Buy Now | Applied Therapeutics | $5.24 | -57.06% | $2.5 → $2.25 | Maintains | Equal-Weight | Get Alert |
| 08/05/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -23.65% | $110 → $113 | Maintains | Overweight | Get Alert |
| 08/01/2022 | PFE | Buy Now | Pfizer | $29.20 | 78.08% | $50 → $52 | Maintains | Equal-Weight | Get Alert |
| 08/01/2022 | ABBV | Buy Now | AbbVie | $168.03 | -4.78% | $174 → $160 | Maintains | Equal-Weight | Get Alert |
| 07/29/2022 | MRK | Buy Now | Merck & Co | $128.30 | -21.28% | $97 → $101 | Maintains | Overweight | Get Alert |
| 07/21/2022 | BIIB | Buy Now | Biogen | $222.07 | -9.94% | $210 → $200 | Maintains | Equal-Weight | Get Alert |
| 05/11/2022 | ALLK | Buy Now | Allakos | $0.91 | 175.91% | $7 → $2.5 | Maintains | Underweight | Get Alert |
| 05/11/2022 | ALEC | Buy Now | Alector | $5.73 | 144.33% | $42 → $14 | Maintains | Overweight | Get Alert |
| 05/04/2022 | BIIB | Buy Now | Biogen | $222.07 | -5.44% | $219 → $210 | Maintains | Equal-Weight | Get Alert |
| 05/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $40.15 | 69.36% | $66 → $68 | Maintains | Equal-Weight | Get Alert |
| 04/26/2022 | GOSS | Buy Now | Gossamer Bio | $1.18 | 916.95% | $18 → $12 | Maintains | Overweight | Get Alert |
| 04/12/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.08K | -31.15% | $700 → $745 | Maintains | Overweight | Get Alert |
| 04/12/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -25.68% | $100 → $110 | Maintains | Overweight | Get Alert |
| 04/12/2022 | MRK | Buy Now | Merck & Co | $128.30 | -24.4% | $94 → $97 | Maintains | Overweight | Get Alert |
| 04/12/2022 | BIIB | Buy Now | Biogen | $222.07 | -1.38% | $235 → $219 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | AMGN | Buy Now | Amgen | $330.34 | -28.56% | $233 → $236 | Maintains | Equal-Weight | Get Alert |
| 04/12/2022 | ABBV | Buy Now | AbbVie | $168.03 | 3.55% | $150 → $174 | Maintains | Equal-Weight | Get Alert |
| 03/30/2022 | MTEM | Buy Now | Molecular Templates | $1.38 | 226.09% | $120 → $67.5 | Maintains | Overweight | Get Alert |
| 03/21/2022 | VOR | Buy Now | Vor Biopharma | $0.97 | 2578.48% | $56 → $26 | Maintains | Overweight | Get Alert |
| 03/21/2022 | APLT | Buy Now | Applied Therapeutics | $5.24 | -52.29% | $7 → $2.5 | Maintains | Equal-Weight | Get Alert |
| 03/10/2022 | GILD | Buy Now | Gilead Sciences | $70.81 | -20.92% | $63 → $56 | Maintains | Underweight | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $330.34 | -29.47% | $228 → $233 | Maintains | Equal-Weight | Get Alert |
| 02/03/2022 | ABBV | Buy Now | AbbVie | $168.03 | -10.73% | $133 → $150 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | PAYC | Buy Now | Paycom Software | $157.00 | 142.04% | $392 → $380 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | NBIX | Buy Now | Neurocrine Biosciences | $148.00 | -32.43% | $110 → $100 | Maintains | Overweight | Get Alert |
| 01/20/2022 | BIIB | Buy Now | Biogen | $222.07 | 9.88% | $280 → $244 | Maintains | Equal-Weight | Get Alert |
| 01/20/2022 | ABBV | Buy Now | AbbVie | $168.03 | -20.85% | $118 → $133 | Maintains | Equal-Weight | Get Alert |
| 01/04/2022 | APLT | Buy Now | Applied Therapeutics | $5.24 | 33.59% | $44 → $7 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 12/22/2021 | ALLK | Buy Now | Allakos | $0.91 | 782.9% | $36 → $8 | Maintains | Underweight | Get Alert |
| 12/20/2021 | LLY | Buy Now | Eli Lilly | $953.00 | -65.9% | — | Maintains | Overweight | Get Alert |
| 12/16/2021 | TVTX | Buy Now | Travere Therapeutics | $9.78 | 309% | — | Maintains | Overweight | Get Alert |
| 12/10/2021 | PFE | Buy Now | Pfizer | $29.20 | 84.93% | — | Maintains | Equal-Weight | Get Alert |
| 12/09/2021 | RETA | Buy Now | Reata Pharmaceuticals | — | — | — | Maintains | Overweight | Get Alert |
